Kalytera Therapeutics (OTCQB:KALTF) announces a major step forward in its program to develop the first cannabinoid -derived pain treatment … Read More
The post Kalytera announces progress with cannabinoid -based compound for treatment of acute and … appeared first on Dagga Magazine.